Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03099850 |
Recruitment Status :
Recruiting
First Posted : April 4, 2017
Last Update Posted : May 5, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Pancreatitis | Other: Data Management and Monitoring |
Study Type : | Observational |
Estimated Enrollment : | 999 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies - PROCEED Study |
Actual Study Start Date : | March 15, 2017 |
Estimated Primary Completion Date : | December 31, 2022 |
Estimated Study Completion Date : | June 30, 2025 |

Group/Cohort | Intervention/treatment |
---|---|
Chronic Pancreatitis |
Other: Data Management and Monitoring
The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer Center responsible for monitoring protocol and regulatory compliance for consortium. CDMC responsible for maintaining and tracking IRB approval and regulatory documents from each site throughout the life of the study. |
- Compliance Monitoring of Regulatory Documents by the Statistician for Consortium Study of Chronic Pancreatitis by CDMC by Implementing Quality Assurance and Quality Control Systems to Ensure Quality Data and Protocol Compliance [ Time Frame: 5 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
1. Participants with chronic pancreatitis.
Exclusion Criteria:
N/A

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03099850
Contact: Li Liang, PHD | 713-563-4276 | lli15@mdanderson.org |
United States, Texas | |
University of Texas MD Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77339 |
Principal Investigator: | Li Liang, PHD | M.D. Anderson Cancer Center |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT03099850 |
Obsolete Identifiers: | NCT04753255 |
Other Study ID Numbers: |
PA17-0104 (2020-1058) 1U01DK108328-01 ( U.S. NIH Grant/Contract ) 2020-1058 ( Other Identifier: MD Anderson Cancer Center ) |
First Posted: | April 4, 2017 Key Record Dates |
Last Update Posted: | May 5, 2022 |
Last Verified: | May 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Chronic Pancreatitis Data management Regulatory compliance Protocol monitoring |
Pancreatitis Pancreatitis, Chronic Pancreatic Diseases Digestive System Diseases |